Javascript must be enabled to continue!
Adrenergic Activity of Ortho-, Meta-, and Para-Octopamine
View through CrossRef
DL-o-, m-, and p-octopamine were tested for β- and α-adrenergic activity in rats. When compared to DL-isoproterenol, a β-adrenergic agonist, all three isomers failed to show significant β-adrenergic activity as assessed by initiation of thirst and by increase in tail skin temperature. All three isomers increased mean blood pressure in pentolinium-blocked rats. Of the three isomers, m-octopamine possessed the greatest α-adrenergic activity. When the responses were compared with those induced by L-norepinephrine, the order of activities was: 1:0.01:0.0005:0.00007 for norepinephrine, m- p- and σ-octopamine, respectively. Thus, DL-m-octopamine has about l/l00th the α-adrenergic activity of L-norepinephrine.
Title: Adrenergic Activity of Ortho-, Meta-, and Para-Octopamine
Description:
DL-o-, m-, and p-octopamine were tested for β- and α-adrenergic activity in rats.
When compared to DL-isoproterenol, a β-adrenergic agonist, all three isomers failed to show significant β-adrenergic activity as assessed by initiation of thirst and by increase in tail skin temperature.
All three isomers increased mean blood pressure in pentolinium-blocked rats.
Of the three isomers, m-octopamine possessed the greatest α-adrenergic activity.
When the responses were compared with those induced by L-norepinephrine, the order of activities was: 1:0.
01:0.
0005:0.
00007 for norepinephrine, m- p- and σ-octopamine, respectively.
Thus, DL-m-octopamine has about l/l00th the α-adrenergic activity of L-norepinephrine.
Related Results
Adrenergic Metabolic and Hemodynamic Effects of Octopamine in the Liver
Adrenergic Metabolic and Hemodynamic Effects of Octopamine in the Liver
The fruit extracts of Citrus aurantium (bitter orange) are traditionally used as weight-loss products and as appetite suppressants. A component of these extracts is octopamine, whi...
PREVENÇÃO DA TROMBOSE VENOSA PROFUNDA NA GRAVIDEZ PELA ENFERMAGEM NA APS
PREVENÇÃO DA TROMBOSE VENOSA PROFUNDA NA GRAVIDEZ PELA ENFERMAGEM NA APS
PREVENÇÃO DA TROMBOSE VENOSA PROFUNDA NA GRAVIDEZ PELA ENFERMAGEM NA APS
Danilo Hudson Vieira de Souza1
Priscilla Bárbara Campos
Daniel dos Santos Fernandes
RESUMO
A gravidez ...
Analysis of octopamine in human doping control samples
Analysis of octopamine in human doping control samples
ABSTRACTThe biogenic amine octopamine [4‐(2‐amino‐1‐hydroxyethyl)phenol] is prohibited in sports owing to its stimulating and performance‐enhancing properties. Adverse analytical f...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Age-Dependent Honey Bee Appetite Regulation Is Mediated by Trehalose and Octopamine Baseline Levels
Age-Dependent Honey Bee Appetite Regulation Is Mediated by Trehalose and Octopamine Baseline Levels
There are multiple feedback mechanisms involved in appetite regulation, which is an integral part of maintaining energetic homeostasis. Older forager honey bees, in comparison to n...
Genotyping Method and Frequency of ADRB3-rs4994 Single Nucleotide Polymorphism Genotypes in Hanoi 3-5 Years Old Chidren
Genotyping Method and Frequency of ADRB3-rs4994 Single Nucleotide Polymorphism Genotypes in Hanoi 3-5 Years Old Chidren
The Trp64Arg (rs4994) polymorphism in codon 64 of ADRB3 (beta3-adrenergic receptor) gene is involved in the regulation of energy metabolism. This study optimizes the genotyping met...
Adrenergic Regulation of Vascular Smooth Muscle
Adrenergic Regulation of Vascular Smooth Muscle
Abstract
The sections in this article are:
Morphology of Adrenergic Innervation
...
Beta-adrenergic blocker treatment for COVID-19
Beta-adrenergic blocker treatment for COVID-19
More than 2.5 million people were affected by COVID-19 and it had caused around 175000 deaths as of April 23, 2020. Currently no effective treatment option is present for COVID-19 ...

